Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029

NCT05428449 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenetic Alopecia
Acne Vulgaris

Interventions

DRUG: GT20029 Gel
DRUG: GT20029 Gel Placebo

Sponsor

Suzhou Kintor Pharmaceutical Inc,